Division of Allergy and Immunology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Allergy Asthma Clin Immunol. 2011 Nov 10;7 Suppl 1(Suppl 1):S9. doi: 10.1186/1710-1492-7-S1-S9.
Urticaria (hives) is a common disorder that often presents with angioedema (swelling that occurs beneath the skin). It is generally classified as acute, chronic or physical. Second-generation, non-sedating H1-receptor antihistamines represent the mainstay of therapy for both acute and chronic urticaria. Angioedema can occur in the absence of urticaria, with angiotensin-converting enzyme (ACE) inhibitor-induced angioedema and idiopathic angioedema being the more common causes. Rarer causes are hereditary angioedema (HAE) or acquired angioedema (AAE). Although the angioedema associated with these disorders is often self-limited, laryngeal involvement can lead to fatal asphyxiation in some cases. The management of HAE and AAE involves both prophylactic strategies to prevent attacks of angioedema (i.e., trigger avoidance, attenuated androgens, tranexamic acid, and plasma-derived C1 inhibitor replacement therapy) as well as pharmacological interventions for the treatment of acute attacks (i.e., C1 inhibitor replacement therapy, ecallantide and icatibant). In this article, the authors review the causes, diagnosis and management of urticaria (with or without angioedema) as well as the work-up and management of isolated angioedema, which vary considerably from that of angioedema that occurs in the presence of urticaria.
荨麻疹(风团)是一种常见疾病,常伴有血管性水肿(皮肤下发生的肿胀)。它通常分为急性、慢性或物理性。第二代、非镇静 H1 受体抗组胺药是治疗急性和慢性荨麻疹的主要药物。血管性水肿可在无荨麻疹的情况下发生,血管紧张素转换酶(ACE)抑制剂诱导的血管性水肿和特发性血管性水肿较为常见。较罕见的病因是遗传性血管性水肿(HAE)或获得性血管性水肿(AAE)。尽管这些疾病相关的血管性水肿通常是自限性的,但喉部受累在某些情况下可导致致命性窒息。HAE 和 AAE 的管理包括预防血管性水肿发作的预防策略(即避免触发因素、减弱雄激素、氨甲环酸和血浆衍生的 C1 抑制剂替代治疗)以及急性发作的药物干预(即 C1 抑制剂替代治疗、艾卡替班和伊卡特班)。本文作者综述了荨麻疹(有或无血管性水肿)的病因、诊断和管理,以及孤立性血管性水肿的检查和管理,这与伴有荨麻疹的血管性水肿的检查和管理有很大不同。